LongeviPAC Supports Lawmakers that Support the Following Proposals:
Increasing funding to the National Institute of Aging – Division of Aging Biology, to advance foundational and translational gerotherapeutic development.
Prioritizing discovery in biology of aging and longevity medicine a focus of ARPA-H, DARPA, and other ARPA-organized entities.
Demand FDA regulators, through legislative action, define approved biomarkers endpoints of clinical trials for aging therapeutics.
Support legislation, like the Alliance for Longevity Initiatives AAPLM policy paper proposal, to establish a dedicated FDA regulatory pathway to prioritize the development of longevity medicines.
Support funding for Congressional-backed research, through agencies, like CRS, NIH and CBO, studying the economic benefits of introducing effective aging therapeutics to populations.
Support proposals to tie insurance rates to time and effort individuals spend on preventing chronic, age-related diseases, including potential tax-relief
Support the proposal of setting a time-bound goal of increasing life expectancy in the United States to 85 by 2035, and healthy life expectancy to 75
Actions That a Politician Can Take to Get the Support of LongeviPAC
To gain the support of LongeviPAC, a politician can engage in several actions that align with our mission to advance longevity science and biotechnology and increase healthy lifespan in the US. Here are some key actions we look for:
Advocacy on Social Media: Tweet positive messages and share content on social media platforms that highlight the importance of “longevity” science and why it is needed to combat the impending “silver tsunami” demographic crisis. Engaging with LongeviPAC’s social media content and promoting discussions around healthy aging can significantly boost visibility and support.
Support for Innovative Legislation: Actively vote for bills and legislative measures that LongeviPAC and related longevity stakeholders support. Demonstrating a consistent voting record in favor of legislation that has clear potential to increase healthy life expectancy in the US, regardless of whether it’s longevity biotechnology specific, shows commitment to advancing our shared goals.
Engage with the Scientific and Patient Advocacy Community: Actively engage with scientists, researchers, industry leaders and patient advocates in the longevity field. Attend conferences, visiting research institutions, and participating in discussions can help stay informed about the latest advancements and foster collaborative efforts. Participate in public forums, debates, and events that focus on longevity science and its benefits to society.
Possess Relevant Expertise: Having a background in biology, particularly in the biology of aging or an age-related disease. This expertise will not only enhance understanding of the field on Capitol Hill, but also lend credibility to other advocacy efforts for longevity research and biotechnology.
Initiate Legislative Proposals: Propose and support new legislative measures that align with the goals of increasing healthy lifespan and advancing longevity science. Being proactive in legislative initiatives demonstrates leadership and dedication to the cause.
Candidates LongeviPAC supports in the 2024 elections:
Check back in early Fall of 2024!